Orca Pharmaceuticals orcapharmaceuticals.com


Public lists: Pharma Startups (4733)

Orca Pharmaceuticals is developing oral drugs for the treatment of chronic inflammatory disease. The company has a medicinal chemistry programme producing orally available inhibitors of a nuclear hormone receptor found in a class of white blood cell involved in autoimmune disease. These pathological pathways are already validated in man by monoclonal antibodies, though the target selected by Orca offers considerable therapeutic benefits and the company is focussed on establishing human proof of ...Show all

Orca Pharmaceuticals is developing oral drugs for the treatment of chronic inflammatory disease. The company has a medicinal chemistry programme producing orally available inhibitors of a nuclear hormone receptor found in a class of white blood cell ...Show all

Company (Alive / Active)

Phone: +44 1235 841542

Fax:

The Innovation Centre
99 Milton Drive, Milton Park
Abingdon, OX14 4RY
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Orca Pharmaceuticals $2.6M Aug 14, 2014

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Orca Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Indolyl-containing rorĪ³t inhibitors Nov 08, 2016 Jan 09, 2018 Patent
Compounds Mar 18, 2016 Dec 20, 2016 Patent
Indazole and indole derivatives as inhibitors of retinoic acid relates orphan receptor gamma (ror gamma) for the treatment of immune-related diseases Oct 23, 2015 Application